Global AI in Precision Medicine Market - 2025-2033
Global AI in Precision Medicine Market – Industry Trends & Outlook
The global AI in precision medicine market reached US$ 1,703.19 Million in 2024 and is expected to reach US$ 6,587.30 Million by 2033, growing at a CAGR of 38.7 % during the forecast period of 2025-2033.
AI in precision medicine involves leveraging artificial intelligence algorithms to process and interpret large volumes of patient data, such as genetic, environmental, and clinical information, to tailor medical treatments and diagnoses to each individual.
Key drivers fueling this market include the rising demand for tailored therapies, the growing prevalence of chronic and life-threatening diseases, and rapid advancements in genomics and multi-omics technologies. The integration of AI enables the processing of complex biomedical data for more accurate diagnostics, biomarker identification, and personalized treatment planning.
Opportunities in the AI in precision medicine market are expanding as more companies embrace collaborations, partnerships, and the integration of real-world evidence (RWE) to streamline drug discovery, clinical trial design, and patient stratification.
Industry trends indicate a shift toward AI-powered tools for early disease detection, personalized drug development, and real-time disease management through wearables and remote monitoring. Major players are investing in AI platforms that can analyze multi-modal data, while regulatory and data privacy challenges remain areas of focus as the market matures.
Global AI in Precision Medicine Market Dynamics: Drivers & Restraints
Advancements in AI Technologies
Advancements in AI technologies are a major driver in the global AI in precision medicine market, fundamentally transforming how patient data is analyzed and used for personalized healthcare. Modern AI, including deep learning and machine learning, can process and interpret vast, complex datasets from genomics, proteomics, medical imaging, and electronic health records with unprecedented speed and accuracy.
These technologies enable the rapid identification of biomarkers, prediction of disease risk, and development of tailored treatment strategies, moving beyond traditional one-size-fits-all approaches. Innovations such as generative AI, digital pathology, and continuous learning systems are streamlining clinical workflows, automating diagnostics, and accelerating drug discovery.
AI-powered platforms can deliver biomarker results in minutes, assist in early cancer detection by analyzing medical images, and predict protein structures critical for drug development. These advancements not only improve diagnostic precision and treatment outcomes but also reduce costs and increase efficiency across healthcare systems.
For instance, in March 2025, Google is launching TxGemma, a collection of open AI models specifically designed to accelerate drug discovery and therapeutic development. Built on Google DeepMind’s Gemma architecture, TxGemma is trained to understand both natural language and the complex structures of therapeutic entities such as small molecules, chemicals, and proteins.
Also, in January 2024, Siemens Healthineers and the Indian Institute of Science (IISc) launched a collaborative laboratory in Bengaluru dedicated to using artificial intelligence (AI) for precision medicine in neurology research. This state-of-the-art lab will focus on developing open-source AI tools that automate the precise segmentation of pathological findings in neuroimaging data-essentially using AI to identify and analyze abnormalities in brain scans. All these factors demand global AI in the precision medicine market.
Data Privacy and Security Concerns
Data privacy and security concerns present significant restraints in the global AI in precision medicine market. As AI algorithms require large volumes of patient data to function effectively, there is growing anxiety about who controls and accesses this sensitive information, especially in the absence of harmonized regulations.
Risks include the potential for re-identification of anonymized data, unauthorized data sharing, and breaches of confidentiality, all of which threaten patient trust and could expose intimate health details. Despite efforts to de-identify datasets, advanced AI techniques have demonstrated the ability to re-link data to individuals, amplifying concerns about data misuse and the adequacy of existing safeguards.
The regulatory landscape is evolving but remains fragmented, with new state and national laws emerging to address gaps left by frameworks like HIPAA. However, enforcement has often lagged behind technological advances, and past incidents of data misuse by major companies highlight the need for stronger oversight.
To mitigate these risks, organizations must adopt robust privacy-preserving techniques, implement strict data governance, and ensure compliance with emerging privacy laws. Without these measures, the risk of data breaches, loss of anonymity, and erosion of public trust could significantly hinder the adoption and growth of AI in precision medicine. Thus, the above factors could be limiting the global AI in the precision medicine market's potential growth.
Global AI in Precision Medicine Market - Segment Analysis
The global AI in precision medicine market is segmented based on technology, component, application, and region.
Component:
The software segment was valued at US$ 638.53 million in 2024 and is estimated to reach US$ 1,366.36 million by 2033, growing at a CAGR of 32-35% during the forecast period from 2025-2033
This segment includes AI algorithms and models, data analytics platforms, genomic analysis software, and clinical decision support systems that enable the processing, integration, and interpretation of vast and complex healthcare data for personalized medicine applications.
Software solutions are essential for analyzing genetic, clinical, and lifestyle data, supporting tasks such as predictive modeling, biomarker discovery, disease diagnosis, and personalized treatment planning. The rapid adoption of AI-based software platforms by healthcare providers and pharmaceutical companies is driven by the need for improved diagnostic accuracy, optimized treatment regimens, and accelerated drug discovery.
Continuous advancements in machine learning, deep learning, and natural language processing are further enhancing the capabilities and effectiveness of these software tools, solidifying the segment's dominance and fueling significant growth in the AI-driven precision medicine landscape.
For instance, in May 2024, OM1 launched three new products- OM1 Orion, OM1 Lyra, and OM1 Polaris- powered by its PhenOM artificial intelligence platform, which specializes in digital phenotyping for personalized medicine and clinical research. PhenOM leverages OM1’s vast, high-quality data cloud, containing billions of data points from over 340 million patients, to generate detailed digital phenotypes- unique, data-driven profiles of patient characteristics and disease patterns. These factors have solidified the segment's position in the global AI in precision medicine market.
Global AI in Precision Medicine Market – Geographical Analysis
The North America AI in precision medicine market was valued at US$ 730.02 million in 2024 and is estimated to reach US$ 1,574.60 million by 2033, growing at a CAGR of 36-38% during the forecast period from 2025-2033
This regional dominance is fueled by several interrelated drivers. There is a strong demand for personalized medicine, as the region faces a high and rising prevalence of chronic and life-threatening diseases, including cancer, cardiovascular, and respiratory conditions. This has prompted healthcare systems, pharmaceutical companies, and technology providers to invest heavily in AI-driven solutions that can tailor treatments and improve patient outcomes.
Another key driver is North America’s robust research and development infrastructure, supported by significant public and private funding. The presence of leading technology firms and healthcare innovators, such as Google Health and Tempus, fosters a climate of rapid technological adoption and collaboration. These companies are advancing AI applications in genomics, diagnostics, and drug discovery, often through strategic partnerships and joint ventures with hospitals, research institutes, and other industry players.
Additionally, the region benefits from a supportive regulatory environment, with agencies like the U.S. FDA guiding AI/ML applications in medicine. The widespread use of electronic health records (EHRs) and real-world evidence (RWE) platforms also provides the rich, structured data necessary for developing and validating AI models. This data ecosystem, combined with a diverse patient population, enables more accurate and generalizable AI-driven precision medicine solutions.
North America’s leadership in the AI in precision medicine market is underpinned by its high healthcare expenditures, advanced digital health infrastructure, and a collaborative approach among technology, healthcare, and academic sectors. These factors collectively drive innovation, accelerate the adoption of AI-powered personalized medicine, and set the pace for global market growth.
For instance, in the US, in April 2025, Precision for Medicine and PathAI announced a strategic collaboration to advance AI-powered clinical trial services and biospecimen products. This partnership will integrate PathAI’s advanced digital pathology technologies-including the AISight image management system and AI-driven algorithms-into Precision for Medicine’s clinical trial and biospecimen operations.
The goal is to deliver novel analytical tools and services that address emerging needs in biomarker discovery, spatial biology, and tissue-based research. Thus, the above factors are consolidating the region's position as a dominant force in the global AI in precision medicine market.
The Asia-Pacific AI in precision medicine market was valued at US$ 360.95 million in 2024 and is estimated to reach US$ 803.11 million by 2033, growing at a CAGR of 40-42% during the forecast period from 2025-2033
The Asia-Pacific (APAC) region is emerging as one of the fastest-growing markets for AI in precision medicine, driven by increasing healthcare needs, digital transformation, and rising investments in biomedical research. Countries such as China, Japan, South Korea, India, Singapore, and Australia are leading the regional adoption, each contributing unique strengths, ranging from AI innovation and genomic research to large-scale healthcare digitization.
Japan is rapidly advancing next-generation drug design, healthcare robotics, and digital health platforms by integrating sovereign AI capabilities across its pharmaceutical, medical technology, and academic sectors. For instance, in June 2024, SoftBank Group Corp. and Tempus AI, Inc. formed a joint venture, SB TEMPUS Corp., to deliver precision medicine services in Japan by leveraging advanced artificial intelligence and Tempus’ expertise in healthcare data analytics.
For instance, in April 2024, iCarbonX is a leading Chinese healthcare company specializing in AI-driven precision medicine by integrating and analyzing diverse datasets, such as genomics, clinical records, lifestyle, and environmental factors. Founded by genomics pioneer Jun Wang, the company uses advanced artificial intelligence and machine learning algorithms to process multi-omics data-including genetic, metabolic, microbiome, and behavioral information-to generate highly personalized health profiles and actionable insights. Thus, the above factors are consolidating the region's position as a dominant force in the global AI in precision medicine market.
Global AI in Precision Medicine Market – Competitive Landscape (Major Players)
The major global players in the AI in precision medicine market include IBM Corporation, Microsoft Corporation, AstraZeneca, Sanofi, GE Healthcare, Intel Corporation, NVIDIA Corporation, Alphabet Inc., BioXcel Therapeutics Inc., Enlitic Inc., Google Inc., and Illumina Inc., among others.
Global AI in Precision Medicine Market – Competitive Landscape (Emerging Players)
The emerging players in the AI in precision medicine market include Exscientia, Insilico Medicine, TEMPUS, BenevolentAI, PathAI, Inc., and Guardant Health, Inc., among others.
Global AI in Precision Medicine Market – Key Developments
The global AI in precision medicine market reached US$ 1,703.19 Million in 2024 and is expected to reach US$ 6,587.30 Million by 2033, growing at a CAGR of 38.7 % during the forecast period of 2025-2033.
AI in precision medicine involves leveraging artificial intelligence algorithms to process and interpret large volumes of patient data, such as genetic, environmental, and clinical information, to tailor medical treatments and diagnoses to each individual.
Key drivers fueling this market include the rising demand for tailored therapies, the growing prevalence of chronic and life-threatening diseases, and rapid advancements in genomics and multi-omics technologies. The integration of AI enables the processing of complex biomedical data for more accurate diagnostics, biomarker identification, and personalized treatment planning.
Opportunities in the AI in precision medicine market are expanding as more companies embrace collaborations, partnerships, and the integration of real-world evidence (RWE) to streamline drug discovery, clinical trial design, and patient stratification.
Industry trends indicate a shift toward AI-powered tools for early disease detection, personalized drug development, and real-time disease management through wearables and remote monitoring. Major players are investing in AI platforms that can analyze multi-modal data, while regulatory and data privacy challenges remain areas of focus as the market matures.
Global AI in Precision Medicine Market Dynamics: Drivers & Restraints
Advancements in AI Technologies
Advancements in AI technologies are a major driver in the global AI in precision medicine market, fundamentally transforming how patient data is analyzed and used for personalized healthcare. Modern AI, including deep learning and machine learning, can process and interpret vast, complex datasets from genomics, proteomics, medical imaging, and electronic health records with unprecedented speed and accuracy.
These technologies enable the rapid identification of biomarkers, prediction of disease risk, and development of tailored treatment strategies, moving beyond traditional one-size-fits-all approaches. Innovations such as generative AI, digital pathology, and continuous learning systems are streamlining clinical workflows, automating diagnostics, and accelerating drug discovery.
AI-powered platforms can deliver biomarker results in minutes, assist in early cancer detection by analyzing medical images, and predict protein structures critical for drug development. These advancements not only improve diagnostic precision and treatment outcomes but also reduce costs and increase efficiency across healthcare systems.
For instance, in March 2025, Google is launching TxGemma, a collection of open AI models specifically designed to accelerate drug discovery and therapeutic development. Built on Google DeepMind’s Gemma architecture, TxGemma is trained to understand both natural language and the complex structures of therapeutic entities such as small molecules, chemicals, and proteins.
Also, in January 2024, Siemens Healthineers and the Indian Institute of Science (IISc) launched a collaborative laboratory in Bengaluru dedicated to using artificial intelligence (AI) for precision medicine in neurology research. This state-of-the-art lab will focus on developing open-source AI tools that automate the precise segmentation of pathological findings in neuroimaging data-essentially using AI to identify and analyze abnormalities in brain scans. All these factors demand global AI in the precision medicine market.
Data Privacy and Security Concerns
Data privacy and security concerns present significant restraints in the global AI in precision medicine market. As AI algorithms require large volumes of patient data to function effectively, there is growing anxiety about who controls and accesses this sensitive information, especially in the absence of harmonized regulations.
Risks include the potential for re-identification of anonymized data, unauthorized data sharing, and breaches of confidentiality, all of which threaten patient trust and could expose intimate health details. Despite efforts to de-identify datasets, advanced AI techniques have demonstrated the ability to re-link data to individuals, amplifying concerns about data misuse and the adequacy of existing safeguards.
The regulatory landscape is evolving but remains fragmented, with new state and national laws emerging to address gaps left by frameworks like HIPAA. However, enforcement has often lagged behind technological advances, and past incidents of data misuse by major companies highlight the need for stronger oversight.
To mitigate these risks, organizations must adopt robust privacy-preserving techniques, implement strict data governance, and ensure compliance with emerging privacy laws. Without these measures, the risk of data breaches, loss of anonymity, and erosion of public trust could significantly hinder the adoption and growth of AI in precision medicine. Thus, the above factors could be limiting the global AI in the precision medicine market's potential growth.
Global AI in Precision Medicine Market - Segment Analysis
The global AI in precision medicine market is segmented based on technology, component, application, and region.
Component:
The software segment was valued at US$ 638.53 million in 2024 and is estimated to reach US$ 1,366.36 million by 2033, growing at a CAGR of 32-35% during the forecast period from 2025-2033
This segment includes AI algorithms and models, data analytics platforms, genomic analysis software, and clinical decision support systems that enable the processing, integration, and interpretation of vast and complex healthcare data for personalized medicine applications.
Software solutions are essential for analyzing genetic, clinical, and lifestyle data, supporting tasks such as predictive modeling, biomarker discovery, disease diagnosis, and personalized treatment planning. The rapid adoption of AI-based software platforms by healthcare providers and pharmaceutical companies is driven by the need for improved diagnostic accuracy, optimized treatment regimens, and accelerated drug discovery.
Continuous advancements in machine learning, deep learning, and natural language processing are further enhancing the capabilities and effectiveness of these software tools, solidifying the segment's dominance and fueling significant growth in the AI-driven precision medicine landscape.
For instance, in May 2024, OM1 launched three new products- OM1 Orion, OM1 Lyra, and OM1 Polaris- powered by its PhenOM artificial intelligence platform, which specializes in digital phenotyping for personalized medicine and clinical research. PhenOM leverages OM1’s vast, high-quality data cloud, containing billions of data points from over 340 million patients, to generate detailed digital phenotypes- unique, data-driven profiles of patient characteristics and disease patterns. These factors have solidified the segment's position in the global AI in precision medicine market.
Global AI in Precision Medicine Market – Geographical Analysis
The North America AI in precision medicine market was valued at US$ 730.02 million in 2024 and is estimated to reach US$ 1,574.60 million by 2033, growing at a CAGR of 36-38% during the forecast period from 2025-2033
This regional dominance is fueled by several interrelated drivers. There is a strong demand for personalized medicine, as the region faces a high and rising prevalence of chronic and life-threatening diseases, including cancer, cardiovascular, and respiratory conditions. This has prompted healthcare systems, pharmaceutical companies, and technology providers to invest heavily in AI-driven solutions that can tailor treatments and improve patient outcomes.
Another key driver is North America’s robust research and development infrastructure, supported by significant public and private funding. The presence of leading technology firms and healthcare innovators, such as Google Health and Tempus, fosters a climate of rapid technological adoption and collaboration. These companies are advancing AI applications in genomics, diagnostics, and drug discovery, often through strategic partnerships and joint ventures with hospitals, research institutes, and other industry players.
Additionally, the region benefits from a supportive regulatory environment, with agencies like the U.S. FDA guiding AI/ML applications in medicine. The widespread use of electronic health records (EHRs) and real-world evidence (RWE) platforms also provides the rich, structured data necessary for developing and validating AI models. This data ecosystem, combined with a diverse patient population, enables more accurate and generalizable AI-driven precision medicine solutions.
North America’s leadership in the AI in precision medicine market is underpinned by its high healthcare expenditures, advanced digital health infrastructure, and a collaborative approach among technology, healthcare, and academic sectors. These factors collectively drive innovation, accelerate the adoption of AI-powered personalized medicine, and set the pace for global market growth.
For instance, in the US, in April 2025, Precision for Medicine and PathAI announced a strategic collaboration to advance AI-powered clinical trial services and biospecimen products. This partnership will integrate PathAI’s advanced digital pathology technologies-including the AISight image management system and AI-driven algorithms-into Precision for Medicine’s clinical trial and biospecimen operations.
The goal is to deliver novel analytical tools and services that address emerging needs in biomarker discovery, spatial biology, and tissue-based research. Thus, the above factors are consolidating the region's position as a dominant force in the global AI in precision medicine market.
The Asia-Pacific AI in precision medicine market was valued at US$ 360.95 million in 2024 and is estimated to reach US$ 803.11 million by 2033, growing at a CAGR of 40-42% during the forecast period from 2025-2033
The Asia-Pacific (APAC) region is emerging as one of the fastest-growing markets for AI in precision medicine, driven by increasing healthcare needs, digital transformation, and rising investments in biomedical research. Countries such as China, Japan, South Korea, India, Singapore, and Australia are leading the regional adoption, each contributing unique strengths, ranging from AI innovation and genomic research to large-scale healthcare digitization.
Japan is rapidly advancing next-generation drug design, healthcare robotics, and digital health platforms by integrating sovereign AI capabilities across its pharmaceutical, medical technology, and academic sectors. For instance, in June 2024, SoftBank Group Corp. and Tempus AI, Inc. formed a joint venture, SB TEMPUS Corp., to deliver precision medicine services in Japan by leveraging advanced artificial intelligence and Tempus’ expertise in healthcare data analytics.
For instance, in April 2024, iCarbonX is a leading Chinese healthcare company specializing in AI-driven precision medicine by integrating and analyzing diverse datasets, such as genomics, clinical records, lifestyle, and environmental factors. Founded by genomics pioneer Jun Wang, the company uses advanced artificial intelligence and machine learning algorithms to process multi-omics data-including genetic, metabolic, microbiome, and behavioral information-to generate highly personalized health profiles and actionable insights. Thus, the above factors are consolidating the region's position as a dominant force in the global AI in precision medicine market.
Global AI in Precision Medicine Market – Competitive Landscape (Major Players)
The major global players in the AI in precision medicine market include IBM Corporation, Microsoft Corporation, AstraZeneca, Sanofi, GE Healthcare, Intel Corporation, NVIDIA Corporation, Alphabet Inc., BioXcel Therapeutics Inc., Enlitic Inc., Google Inc., and Illumina Inc., among others.
Global AI in Precision Medicine Market – Competitive Landscape (Emerging Players)
The emerging players in the AI in precision medicine market include Exscientia, Insilico Medicine, TEMPUS, BenevolentAI, PathAI, Inc., and Guardant Health, Inc., among others.
Global AI in Precision Medicine Market – Key Developments
- In April 2025, Illumina Inc. and Tempus AI, Inc. announced a strategic collaboration aimed at advancing the clinical adoption of next-generation sequencing (NGS) technologies. This partnership will leverage Illumina’s cutting-edge AI capabilities alongside Tempus’s robust multimodal data platform to develop and train genomic algorithms.
- In January 2025, Guardant Health and ConcertAI announced a collaboration to provide biopharmaceutical companies with the industry’s first multi-modal real-world data (RWD) solution that combines comprehensive patient electronic medical record (EMR) data with both genomic and epigenomic tumor profiling across all stages of cancer care.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Technology
2.4. Snippet by Component
2.5. Snippet by Application
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in AI Technologies
3.1.1.2. Rising Demand for Personalized Medicine
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Data Privacy and Security Concerns
3.1.2.2. High Costs Associated with the Implementation of AI-Driven Precision Medicine
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Integration of Real-World Data
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Regulatory and Reimbursement Landscape
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. South America
4.4.5. Middle East & Africa
4.5. Porter’s Five Forces Analysis
4.6. Supply Chain Analysis
4.7. Patent Analysis
4.8. SWOT Analysis
4.9. Unmet Needs and Gaps
4.10. Recommended Strategies for Market Entry and Expansion
4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.12. Pricing Analysis and Price Dynamics
4.13. Key Opinion Leaders
5. GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECHNOLOGY
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
5.1.2. Market Attractiveness Index, By Technology
5.2. Deep Learning*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Querying Method
5.4. Natural Language Processing
5.5. Context-Aware Processing
6. GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
6.1.2. Market Attractiveness Index, By Component
6.2. Hardware*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Software
6.4. Services
7. GLOBAL AI IN PRECISION MEDICINE MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Oncology*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Neurology
7.5. Respiratory
7.6. Others
8. GLOBAL AI IN PRECISION MEDICINE MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
Key Players
10.1. IBM Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Microsoft Corporation
10.3. AstraZeneca
10.4. Sanofi
10.5. GE Healthcare
10.6. Intel Corporation
10.7. NVIDIA Corporation
10.8. Alphabet Inc
10.9. BioXcel Therapeutics Inc
10.10. Enlitic Inc
10.11. Google Inc.
10.12. Illumina Inc.
Emerging Players
10.13. Exscientia
10.14. Insilico Medicine
10.15. TEMPUS
10.16. BenevolentAI
10.17. PathAI, Inc.
10.18. Guardant Health, Inc.
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Technology
2.4. Snippet by Component
2.5. Snippet by Application
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in AI Technologies
3.1.1.2. Rising Demand for Personalized Medicine
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Data Privacy and Security Concerns
3.1.2.2. High Costs Associated with the Implementation of AI-Driven Precision Medicine
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Integration of Real-World Data
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Regulatory and Reimbursement Landscape
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. South America
4.4.5. Middle East & Africa
4.5. Porter’s Five Forces Analysis
4.6. Supply Chain Analysis
4.7. Patent Analysis
4.8. SWOT Analysis
4.9. Unmet Needs and Gaps
4.10. Recommended Strategies for Market Entry and Expansion
4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.12. Pricing Analysis and Price Dynamics
4.13. Key Opinion Leaders
5. GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECHNOLOGY
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
5.1.2. Market Attractiveness Index, By Technology
5.2. Deep Learning*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Querying Method
5.4. Natural Language Processing
5.5. Context-Aware Processing
6. GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
6.1.2. Market Attractiveness Index, By Component
6.2. Hardware*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Software
6.4. Services
7. GLOBAL AI IN PRECISION MEDICINE MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Oncology*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Neurology
7.5. Respiratory
7.6. Others
8. GLOBAL AI IN PRECISION MEDICINE MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
Key Players
10.1. IBM Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Microsoft Corporation
10.3. AstraZeneca
10.4. Sanofi
10.5. GE Healthcare
10.6. Intel Corporation
10.7. NVIDIA Corporation
10.8. Alphabet Inc
10.9. BioXcel Therapeutics Inc
10.10. Enlitic Inc
10.11. Google Inc.
10.12. Illumina Inc.
Emerging Players
10.13. Exscientia
10.14. Insilico Medicine
10.15. TEMPUS
10.16. BenevolentAI
10.17. PathAI, Inc.
10.18. Guardant Health, Inc.
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global AI in Precision Medicine Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 2 Global AI in Precision Medicine Market Value, By Component, 2025, 2029 & 2033 (US$ Million)
Table 3 Global AI in Precision Medicine Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 4 Global AI in Precision Medicine Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 5 Global AI in Precision Medicine Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 6 Global AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 7 Global AI in Precision Medicine Market Value, By Component, 2025, 2029 & 2033 (US$ Million)
Table 8 Global AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 9 Global AI in Precision Medicine Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 10 Global AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 11 Global AI in Precision Medicine Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 12 Global AI in Precision Medicine Market Value, By Region, 2022-2033 (US$ Million)
Table 13 North America AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 14 North America AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 15 North America AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 16 North America AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 17 South America AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 18 South America AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 19 South America AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 20 South America AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 21 Europe AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 22 Europe AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 23 Europe AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 24 Europe AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 25 Asia-Pacific AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 26 Asia-Pacific AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 27 Asia-Pacific AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 28 Asia-Pacific AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 29 Middle East and Africa AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 30 Middle East and Africa AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 31 Middle East and Africa AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 32 Middle East and Africa AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 33 IBM Corporation: Overview
Table 34 IBM Corporation: Product Portfolio
Table 35 IBM Corporation: Key Developments
Table 36 Microsoft Corporation: Overview
Table 37 Microsoft Corporation: Product Portfolio
Table 38 Microsoft Corporation: Key Developments
Table 39 AstraZeneca: Overview
Table 40 AstraZeneca: Product Portfolio
Table 41 AstraZeneca: Key Developments
Table 42 Sanofi: Overview
Table 43 Sanofi: Product Portfolio
Table 44 Sanofi: Key Developments
Table 45 GE Healthcare: Overview
Table 46 GE Healthcare: Product Portfolio
Table 47 GE Healthcare: Key Developments
Table 48 Intel Corporation: Overview
Table 49 Intel Corporation: Product Portfolio
Table 50 Intel Corporation: Key Developments
Table 51 NVIDIA Corporation: Overview
Table 52 NVIDIA Corporation: Product Portfolio
Table 53 NVIDIA Corporation: Key Developments
Table 54 Alphabet Inc: Overview
Table 55 Alphabet Inc.: Product Portfolio
Table 56 Alphabet Inc: Key Developments
Table 57 BioXcel Therapeutics Inc: Overview
Table 58 BioXcel Therapeutics Inc: Product Portfolio
Table 59 BioXcel Therapeutics Inc: Key Developments
Table 60 Enlitic Inc: Overview
Table 61 Enlitic Inc: Product Portfolio
Table 62 Enlitic Inc: Key Developments
Table 63 Google Inc.: Overview
Table 64 Google Inc.: Product Portfolio
Table 65 Google Inc.: Key Developments
Table 66 Illumina Inc.: Overview
Table 67 Illumina Inc.: Product Portfolio
Table 68 Illumina Inc.: Key Developments
Table 69 Exscientia: Overview
Table 70 Exscientia: Product Portfolio
Table 71 Exscientia: Key Developments
Table 72 Insilico Medicine: Overview
Table 73 Insilico Medicine: Product Portfolio
Table 74 Insilico Medicine: Key Developments
Table 75 TEMPUS: Overview
Table 76 TEMPUS: Product Portfolio
Table 77 TEMPUS: Key Developments
Table 78 BenevolentAI: Overview
Table 79 BenevolentAI: Product Portfolio
Table 80 BenevolentAI: Key Developments
Table 81 PathAI, Inc.: Overview
Table 82 PathAI, Inc.: Product Portfolio
Table 83 PathAI, Inc.: Key Developments
Table 84 Guardant Health, Inc.: Overview
Table 85 Guardant Health, Inc.: Product Portfolio
Table 86 Guardant Health, Inc.: Key Developments
Table 1 Global AI in Precision Medicine Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 2 Global AI in Precision Medicine Market Value, By Component, 2025, 2029 & 2033 (US$ Million)
Table 3 Global AI in Precision Medicine Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 4 Global AI in Precision Medicine Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 5 Global AI in Precision Medicine Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 6 Global AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 7 Global AI in Precision Medicine Market Value, By Component, 2025, 2029 & 2033 (US$ Million)
Table 8 Global AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 9 Global AI in Precision Medicine Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 10 Global AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 11 Global AI in Precision Medicine Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 12 Global AI in Precision Medicine Market Value, By Region, 2022-2033 (US$ Million)
Table 13 North America AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 14 North America AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 15 North America AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 16 North America AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 17 South America AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 18 South America AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 19 South America AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 20 South America AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 21 Europe AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 22 Europe AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 23 Europe AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 24 Europe AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 25 Asia-Pacific AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 26 Asia-Pacific AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 27 Asia-Pacific AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 28 Asia-Pacific AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 29 Middle East and Africa AI in Precision Medicine Market Value, By Technology, 2022-2033 (US$ Million)
Table 30 Middle East and Africa AI in Precision Medicine Market Value, By Component, 2022-2033 (US$ Million)
Table 31 Middle East and Africa AI in Precision Medicine Market Value, By Application, 2022-2033 (US$ Million)
Table 32 Middle East and Africa AI in Precision Medicine Market Value, By Country, 2022-2033 (US$ Million)
Table 33 IBM Corporation: Overview
Table 34 IBM Corporation: Product Portfolio
Table 35 IBM Corporation: Key Developments
Table 36 Microsoft Corporation: Overview
Table 37 Microsoft Corporation: Product Portfolio
Table 38 Microsoft Corporation: Key Developments
Table 39 AstraZeneca: Overview
Table 40 AstraZeneca: Product Portfolio
Table 41 AstraZeneca: Key Developments
Table 42 Sanofi: Overview
Table 43 Sanofi: Product Portfolio
Table 44 Sanofi: Key Developments
Table 45 GE Healthcare: Overview
Table 46 GE Healthcare: Product Portfolio
Table 47 GE Healthcare: Key Developments
Table 48 Intel Corporation: Overview
Table 49 Intel Corporation: Product Portfolio
Table 50 Intel Corporation: Key Developments
Table 51 NVIDIA Corporation: Overview
Table 52 NVIDIA Corporation: Product Portfolio
Table 53 NVIDIA Corporation: Key Developments
Table 54 Alphabet Inc: Overview
Table 55 Alphabet Inc.: Product Portfolio
Table 56 Alphabet Inc: Key Developments
Table 57 BioXcel Therapeutics Inc: Overview
Table 58 BioXcel Therapeutics Inc: Product Portfolio
Table 59 BioXcel Therapeutics Inc: Key Developments
Table 60 Enlitic Inc: Overview
Table 61 Enlitic Inc: Product Portfolio
Table 62 Enlitic Inc: Key Developments
Table 63 Google Inc.: Overview
Table 64 Google Inc.: Product Portfolio
Table 65 Google Inc.: Key Developments
Table 66 Illumina Inc.: Overview
Table 67 Illumina Inc.: Product Portfolio
Table 68 Illumina Inc.: Key Developments
Table 69 Exscientia: Overview
Table 70 Exscientia: Product Portfolio
Table 71 Exscientia: Key Developments
Table 72 Insilico Medicine: Overview
Table 73 Insilico Medicine: Product Portfolio
Table 74 Insilico Medicine: Key Developments
Table 75 TEMPUS: Overview
Table 76 TEMPUS: Product Portfolio
Table 77 TEMPUS: Key Developments
Table 78 BenevolentAI: Overview
Table 79 BenevolentAI: Product Portfolio
Table 80 BenevolentAI: Key Developments
Table 81 PathAI, Inc.: Overview
Table 82 PathAI, Inc.: Product Portfolio
Table 83 PathAI, Inc.: Key Developments
Table 84 Guardant Health, Inc.: Overview
Table 85 Guardant Health, Inc.: Product Portfolio
Table 86 Guardant Health, Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 2 Global AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 3 Global AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 4 Global AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global AI in Precision Medicine Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global AI in Precision Medicine Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 7 Deep Learning AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 8 Querying Method AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 9 Natural Language Processing AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 10 Context Aware Processing AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 11 Global AI in Precision Medicine Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 12 Hardware Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 13 Software Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 14 Services Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 15 Global AI in Precision Medicine Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 16 Oncology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 17 Cardiology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 18 Neurology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 19 Respiratory Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 20 Other Applications in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 21 Global AI in Precision Medicine Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 22 North America AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 23 North America AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 24 North America AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 25 North America AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 26 North America AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 27 South America AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 28 South America AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 29 South America AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 30 South America AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 31 South America AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 33 Europe AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 34 Europe AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 35 Europe AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 37 Asia-Pacific AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 38 Asia-Pacific AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 39 Asia-Pacific AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 40 Asia-Pacific AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 42 Middle East and Africa AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 43 Middle East and Africa AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 44 Middle East and Africa AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 45 Middle East and Africa AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 46 IBM Corporation: Financials
Figure 47 Microsoft Corporation: Financials
Figure 48 AstraZeneca: Financials
Figure 49 Sanofi: Financials
Figure 50 GE Healthcare: Financials
Figure 51 Intel Corporation: Financials
Figure 52 NVIDIA Corporation: Financials
Figure 53 Alphabet Inc: Financials
Figure 54 BioXcel Therapeutics Inc: Financials
Figure 55 Enlitic Inc: Financials
Figure 56 Google Inc.: Financials
Figure 57 Illumina Inc.: Financials
Figure 58 Exscientia: Financials
Figure 59 Insilico Medicine: Financials
Figure 60 TEMPUS: Financials
Figure 61 BenevolentAI: Financials
Figure 62 PathAI, Inc.: Financials
Figure 63 Guardant Health, Inc.: Financials
Figure 1 Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 2 Global AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 3 Global AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 4 Global AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global AI in Precision Medicine Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global AI in Precision Medicine Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 7 Deep Learning AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 8 Querying Method AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 9 Natural Language Processing AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 10 Context Aware Processing AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 11 Global AI in Precision Medicine Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 12 Hardware Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 13 Software Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 14 Services Component in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 15 Global AI in Precision Medicine Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 16 Oncology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 17 Cardiology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 18 Neurology Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 19 Respiratory Application in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 20 Other Applications in Global AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 21 Global AI in Precision Medicine Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 22 North America AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 23 North America AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 24 North America AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 25 North America AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 26 North America AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 27 South America AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 28 South America AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 29 South America AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 30 South America AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 31 South America AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 33 Europe AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 34 Europe AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 35 Europe AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 37 Asia-Pacific AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 38 Asia-Pacific AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 39 Asia-Pacific AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 40 Asia-Pacific AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific AI in Precision Medicine Market Share, By Country, 2024 & 2033 (%)
Figure 42 Middle East and Africa AI in Precision Medicine Market Value, 2022-2033 (US$ Million)
Figure 43 Middle East and Africa AI in Precision Medicine Market Share, By Technology, 2024 & 2033 (%)
Figure 44 Middle East and Africa AI in Precision Medicine Market Share, By Component, 2024 & 2033 (%)
Figure 45 Middle East and Africa AI in Precision Medicine Market Share, By Application, 2024 & 2033 (%)
Figure 46 IBM Corporation: Financials
Figure 47 Microsoft Corporation: Financials
Figure 48 AstraZeneca: Financials
Figure 49 Sanofi: Financials
Figure 50 GE Healthcare: Financials
Figure 51 Intel Corporation: Financials
Figure 52 NVIDIA Corporation: Financials
Figure 53 Alphabet Inc: Financials
Figure 54 BioXcel Therapeutics Inc: Financials
Figure 55 Enlitic Inc: Financials
Figure 56 Google Inc.: Financials
Figure 57 Illumina Inc.: Financials
Figure 58 Exscientia: Financials
Figure 59 Insilico Medicine: Financials
Figure 60 TEMPUS: Financials
Figure 61 BenevolentAI: Financials
Figure 62 PathAI, Inc.: Financials
Figure 63 Guardant Health, Inc.: Financials
